[Treatment of prostatic carcinoma with orally administered Estracyt].
D000284:Administration, Oral; D002219:Carbamates / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D004962:Estranes / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013997:Time Factors
D002219:Carbamates; D004962:Estranes; D009588:Nitrogen Mustard Compounds; D009943:Organophosphorus Compounds
Orale Estracyt -Behandlung beim Prostatakarzinom